https://leerink.com/cpe-newsletter/ 2026-06-30T13:04:47+00:00 https://leerink.com/cpe-newsletter/the-eras-tour-of-healthcare-innovation-mels-version/ 2025-03-10T18:05:55+00:00 https://leerink.com/cpe-newsletter/the-prices-we-pay-for-drugs-today-send-signals-to-investors-and-innovator/ 2025-03-10T18:11:23+00:00 https://leerink.com/cpe-newsletter/the-market-based-price-for-attruby-is-worth-it/ 2025-03-10T18:20:11+00:00 https://leerink.com/wp-content/uploads/2025/03/unnamed.png https://leerink.com/cpe-newsletter/cost-effectiveness-analysis-can-create-an-unlevel-playing-field/ 2025-03-10T18:30:11+00:00 https://leerink.com/cpe-newsletter/generic-drugs-approved-in-2022-saved-19-billion-within-a-year/ 2025-03-10T18:46:05+00:00 https://leerink.com/wp-content/uploads/2025/03/unnamed-4.png https://leerink.com/cpe-newsletter/the-world-is-not-aware-of-how-healthcare-innovation-occurs/ 2025-03-10T18:54:59+00:00 https://leerink.com/wp-content/uploads/2025/03/unnamed-1-1.png https://leerink.com/wp-content/uploads/2025/03/unnamed-5.png https://leerink.com/cpe-newsletter/removing-the-pill-penalty-could-reduce-healthcare-spending/ 2025-03-10T19:01:15+00:00 https://leerink.com/cpe-newsletter/the-market-based-price-for-cobenfy-is-worth-it/ 2025-03-10T19:03:07+00:00 https://leerink.com/wp-content/uploads/2025/03/unnamed-1.png https://leerink.com/wp-content/uploads/2025/03/unnamed-2.png https://leerink.com/wp-content/uploads/2025/03/unnamed-3.png https://leerink.com/cpe-newsletter/pharmacoeconomics-can-bridge-the-gap-between-the-shareholder-and-the-stakeholder/ 2025-03-10T19:04:39+00:00 https://leerink.com/cpe-newsletter/comparing-drug-prices-across-countries-doesnt-make-sense/ 2025-03-10T19:10:55+00:00 https://leerink.com/wp-content/uploads/2025/03/unnamed-2-1.png https://leerink.com/wp-content/uploads/2025/03/unnamed-3-1.png https://leerink.com/cpe-newsletter/pharmaceuticals-reduce-the-societal-burden-of-cardiovascular-disease/ 2025-03-10T19:16:00+00:00 https://leerink.com/cpe-newsletter/a-product-lifetime-model-is-the-only-adequate-approach/ 2025-03-10T19:24:45+00:00 https://leerink.com/wp-content/uploads/2025/03/unnamed-4-1.png https://leerink.com/wp-content/uploads/2025/03/unnamed-6.png https://leerink.com/cpe-newsletter/the-market-based-price-for-yorvipath-is-worth-it/ 2025-03-10T19:34:33+00:00 https://leerink.com/wp-content/uploads/2025/03/unnamed-1-2.png https://leerink.com/wp-content/uploads/2025/03/unnamed-2-2.png https://leerink.com/wp-content/uploads/2025/03/unnamed-7.png https://leerink.com/wp-content/uploads/2025/03/unnamed-1-3.png https://leerink.com/cpe-newsletter/calls-for-a-minimum-fair-price-for-medicare-drug-price-negotiations/ 2025-03-10T21:33:03+00:00 https://leerink.com/wp-content/uploads/2025/03/unnamed-8.png https://leerink.com/wp-content/uploads/2025/03/unnamed-1-4.png https://leerink.com/cpe-newsletter/generic-competition-after-the-patent-period-drives-down-healthcare-spending/ 2025-03-10T21:40:17+00:00 https://leerink.com/wp-content/uploads/2025/03/unnamed-9.png https://leerink.com/cpe-newsletter/calls-for-generalized-cost-effectiveness-to-become-the-norm/ 2025-03-10T21:52:52+00:00 https://leerink.com/wp-content/uploads/2025/03/unnamed-10.png https://leerink.com/cpe-newsletter/the-market-based-price-for-dupixent-is-worth-it-for-copd/ 2025-03-10T22:01:21+00:00 https://leerink.com/wp-content/uploads/2025/03/unnamed-11.png https://leerink.com/cpe-newsletter/turns-out-we-werent-fooled/ 2025-04-25T18:02:10+00:00 https://leerink.com/wp-content/uploads/2025/04/image.png https://leerink.com/wp-content/uploads/2025/04/image-1.png https://leerink.com/cpe-newsletter/health-technology-assessment/ 2025-05-20T19:36:39+00:00 https://leerink.com/cpe-newsletter/a-big-limitation-to-an-approach-to-drug-pricing-used-by-many-ex-us-countries/ 2025-05-21T17:11:35+00:00 https://leerink.com/cpe-newsletter/entrestos-medicare-negotiated-price-is-a-head-scratcher/ 2025-05-21T17:12:24+00:00 https://leerink.com/wp-content/uploads/2025/05/image.png https://leerink.com/wp-content/uploads/2025/05/image-1.png https://leerink.com/cpe-newsletter/the-pill-penalty-could-reduce-incentives-for-post-approval-research/ 2025-05-21T17:13:14+00:00 https://leerink.com/cpe-newsletter/president-trump-signs-an-executive-order-supporting-an-end-to-the-pill-penalty/ 2025-05-21T17:14:29+00:00 https://leerink.com/cpe-newsletter/health-policy-and-investing-are-at-an-intersection/ 2025-05-21T17:14:53+00:00 https://leerink.com/wp-content/uploads/2025/04/image-2.png https://leerink.com/cpe-newsletter/accounting-for-the-realities-of-the-marketplace-when-judging-healthcare-innovations/ 2025-05-21T17:15:17+00:00 https://leerink.com/cpe-newsletter/branded-drug-spending-as-an-investment-that-is-eventually-paid-off/ 2025-05-21T17:15:44+00:00 https://leerink.com/cpe-newsletter/the-us-market-based-price-for-zurzuvae-is-worth-it/ 2025-06-03T15:37:25+00:00 https://leerink.com/cpe-newsletter/utilization-management-for-utilization-management/ 2025-06-10T14:55:14+00:00 https://leerink.com/cpe-newsletter/we-cannot-detect-if-there-is-a-market-failure-at-9-years/ 2025-07-01T19:45:05+00:00 https://leerink.com/wp-content/uploads/2025/07/image-1.png https://leerink.com/wp-content/uploads/2025/07/image-2.png https://leerink.com/wp-content/uploads/2025/07/image-3.png https://leerink.com/cpe-newsletter/gcea-and-mark-cuban-changed-how-i-think-about-drug-pricing/ 2025-07-22T19:06:03+00:00 https://leerink.com/cpe-newsletter/glp-1s-for-obesity-are-priced-less-than-the-value-they-provide/ 2025-07-31T15:22:32+00:00 https://leerink.com/wp-content/uploads/2025/07/image-4.png https://leerink.com/cpe-newsletter/generic-entresto-enters-at-a-90-price-discount/ 2025-08-05T15:36:19+00:00 https://leerink.com/wp-content/uploads/2025/08/image.png https://leerink.com/cpe-newsletter/generic-competition-for-xarelto-results-in-a-90-price-drop/ 2025-09-26T14:07:35+00:00 https://leerink.com/wp-content/uploads/2025/09/image.png https://leerink.com/wp-content/uploads/2025/09/image-1.png https://leerink.com/cpe-newsletter/entresto-is-cost-saving-and-my-two-cents-on-the-new-cea-guidelines/ 2025-10-03T14:10:23+00:00 https://leerink.com/wp-content/uploads/2025/10/image.png https://leerink.com/wp-content/uploads/2025/10/image-1.png https://leerink.com/wp-content/uploads/2025/10/image-2.png https://leerink.com/wp-content/uploads/2025/10/image-3.png https://leerink.com/cpe-newsletter/this-isnt-the-first-time-the-repatha-price-has-dropped-60/ 2025-10-10T16:58:36+00:00 https://leerink.com/cpe-newsletter/in-case-you-needed-more-evidence-that-a-drugs-price-falls-off-a-cliff/ 2025-11-07T16:19:33+00:00 https://leerink.com/wp-content/uploads/2025/11/image.png https://leerink.com/cpe-newsletter/are-the-medicare-negotiated-price-drops-larger-for-drugs-that-have-been-on-the-market-longer/ 2025-11-28T14:22:06+00:00 https://leerink.com/wp-content/uploads/2025/11/CPE-Newsletter_11.26.25.png https://leerink.com/cpe-newsletter/what-nices-higher-cost-effectiveness-threshold-means/ 2026-02-26T19:01:05+00:00 https://leerink.com/wp-content/uploads/2025/12/CPE_Newsletter_DiaryHealthEconomist_HERO_1920x1080-1.jpg https://leerink.com/cpe-newsletter/trumprx-adds-600-generics-and-its-a-big-deal/ 2026-06-08T14:21:01+00:00 https://leerink.com/wp-content/uploads/2025/12/CPE_Newsletter_DiaryHealthEconomist_HERO_1920x1080-1.jpg https://leerink.com/cpe-newsletter/health-economics-for-builders-and-backers-5-26/ 2026-06-16T14:34:00+00:00 https://leerink.com/wp-content/uploads/2026/04/image.jpg https://leerink.com/cpe-newsletter/health-economics-for-builders-and-backers-2-2/ 2026-06-16T14:34:49+00:00 https://leerink.com/wp-content/uploads/2026/04/image.jpg https://leerink.com/cpe-newsletter/health-economics-for-builders-and-backers-2/ 2026-06-16T14:35:03+00:00 https://leerink.com/wp-content/uploads/2025/12/CPE_Newsletter_DiaryHealthEconomist_HERO_1920x1080-1.jpg https://leerink.com/cpe-newsletter/health-economics-for-builders-and-backers/ 2026-06-16T14:35:15+00:00 https://leerink.com/wp-content/uploads/2025/12/CPE_Newsletter_DiaryHealthEconomist_HERO_1920x1080-1.jpg https://leerink.com/cpe-newsletter/health-economics-for-builders-and-backers-6-26/ 2026-06-30T13:04:47+00:00 https://leerink.com/wp-content/uploads/2026/04/image.jpg